Clin2
NCT06975683Possibly a fitRecruiting

PRGF ovarian injection for low ovarian reserve

Low Ovarian Reserve

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests a special injection of growth factors from your own blood into the ovary to see if it can improve egg quality and quantity for women with low ovarian reserve. It may be an option if you have been trying to conceive for over a year and have low egg reserve.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are a woman of childbearing age and have been trying to get pregnant for at least a year.
  • You have been diagnosed with low ovarian reserve (high FSH, low AMH, or few eggs seen on ultrasound).
  • You have at least one ovary and are not currently pregnant.
  • You do not smoke heavily (fewer than 15 cigarettes per day) and your BMI is under 30.
  • You are not taking blood thinners, NSAIDs, or aspirin regularly.
  • You do not have a history of severe male infertility in your partner, ongoing cancer, or certain bleeding or immune disorders.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07816562Recruiting· Phase 3
Ovulation trigger options for women with low ovarian reserve

This study compares two different medications used to trigger ovulation in women with low ovarian reserve who are undergoing fertility treatment. The goal is to find which approach leads to better outcomes, such as more eggs retrieved and higher pregnancy chances.

Valencia
NCT03937661Recruiting· Phase 2/Phase 3
Platelet-rich plasma injected into ovaries for poor egg responders

This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.

Athens
NCT07871825Recruiting· Phase 4
Study of G-CSF for diminished ovarian reserve in IVF

This study tests a medicine called G-CSF (given as an injection) to see if it helps improve egg quality and IVF success in women with a lower egg supply (diminished ovarian reserve). If you are between 35 and 44 and have been told your egg count is low but not too low, this might be worth exploring.

New York, New York
NCT07282314Not yet recruiting
Platelet-rich plasma injections for women with poor ovarian response

This study tests a treatment called PRP, which uses a concentration of your own blood platelets to potentially improve ovarian function and response to fertility drugs. It may help women with poor ovarian response or premature ovarian insufficiency who are undergoing IVF.

NCT05181748Recruiting· Phase 2/Phase 3
Platelet-rich plasma into ovaries for low egg response

This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg production in people who don’t respond well to fertility stimulation. It may help some “poor responders” get more usable eggs for IVF.

Athens, Attica
NCT04031456Recruiting· Phase 2/Phase 3
PRP treatment to help ovaries work again in early ovarian failure

This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.

Athens

Hear when a new Low Ovarian Reserve trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.